A prospective, single-centre, cohort study to determine the pharmacokinetic and pharmacodynamic parameters of teicoplanin in adult patients with haematological malignancy.
Phase of Trial: Phase IV
Latest Information Update: 18 Dec 2017
Price : $35 *
At a glance
- Drugs Teicoplanin (Primary)
- Indications Bacterial infections; Mycoses
- Focus Pharmacokinetics
- 18 Dec 2017 Results published in the Journal of Antimicrobial Chemotherapy
- 24 Oct 2015 Status changed from recruiting to completed as per European Clinical Trials Database record.
- 20 Jun 2014 New trial record